Global Molecular Imaging Market, By Technology (Magnetic Resonance Spectroscopy, Optical Imaging, Molecular Ultrasound Imaging), Device Type (Positron Emission Tomography (PET) Scanner, Single Photon Emission Computed Tomography (SPECT) Scanner, Gamma Camera, Nuclear Magnetic Resonance (NMR) Spectrometer, Others), Application (Cardiovascular, Neurology, Respiratory, Oncology, Others), End User (Hospital, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Others) Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The molecular imaging market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 7.51 billion by 2028 and will grow at a CAGR of 6.39% in the above mentioned forecast period.
Molecular imaging technology is largely used for classification and measurement of biological processes at the cellular and molecular level with the help of imaging detectors. Molecular imaging presents more modified approach to assessment and organization of cardiovascular disease conditions.
The rise in demand for detection and monitoring of disease such as cancer and other rare genetic disorders is amongst the important factor expected to intensify the growth and demand of molecular imaging market. In addition, the rapid rise in aging population and the high adoption and advancement in technologies such as PET/CT are also expected contribute to the growth in the global market over the forecast period of 2021 to 2028. Also the non-ionizing imaging techniques and high demand for efficient and accurate imaging system are also likely to enhance the growth of the market. Furthermore, the extensive presence of cancer disorders and rise in need of digitization and novel contrast agents also one of the significant factors expected to fuel the growth of the molecular imaging market.
The rapid rise in adoption of molecular imaging for newer applications, high continuous improvement and innovation in molecular imaging technologies and emerging economies are anticipated to offer significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the some limitations associated with all molecular imaging modalities along with unfavorable reimbursement scenario are expected to curb the growth of the molecular imaging market, whereas the expensive investments can challenge the growth of the molecular imaging market.
This molecular imaging market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the molecular imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Molecular Imaging Market Scope and Market Size
The molecular imaging market is segmented on the basis of technology, device type, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of technology, the molecular imaging market is segmented into magnetic resonance spectroscopy, optical imaging and molecular ultrasound imaging.
- On the basis of device type, the molecular imaging market is segmented into positron emission tomography (PET) scanner, single photon emission computed tomography (SPECT) scanner, gamma camera, nuclear magnetic resonance (NMR) spectrometer and others.
- Based on application, the molecular imaging market is segmented into cardiovascular, neurology, respiratory, oncology and others.
- The end user segment of molecular imaging market is segmented into hospital, diagnostic imaging centers, ambulatory surgical centers and others.
Molecular Imaging Market Country Level Analysis
The molecular imaging market is analyzed and market size insights and trends are provided by country, technology, device type, application and end user as referenced above.
The countries covered in the molecular imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the molecular imaging market owing to the well established healthcare infrastructure and rise in awareness amongst people concerning health coupled with rise in of various diseases counting cardiovascular, cancer and brain disorders. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rise in healthcare funding from government and private organizations to expand technologically advanced medical systems.
The country section of the molecular imaging market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The molecular imaging market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for molecular imaging market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the molecular imaging market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Molecular imaging Market Share Analysis
The molecular imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to molecular imaging market.
The major players covered in the molecular imaging market report are GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Hologic, Inc., Siemens, CANON MEDICAL SYSTEMS CORPORATION, Hitachi, Ltd., BC Technical, Bracco Diagnostic Inc., SAMSUNG, FUJIFILM Corporation, Medtronic, Shimadzu Corporation, ESAOTE SPA, PerkinElmer Inc, Guerbet, Boston Scientific Corporation, Hamamatsu Photonics K.K., Neusoft Corporation, DIGIRAD CORPORATION and Carestream Health, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.